Effects of Pioglitazone in Combination with Metformin or a Sulfonylurea Compared to a Fixed-Dose Combination of Metformin and Glibenclamide in Patients with Type 2 Diabetes

Comaschi, Marco; Demicheli, A; Di Pietro, Caterina; Bellatreccia, A.; Mariz, Segundo; COM06 Study Investigators, the

doi:10.1089/dia.2006.0023

Public

Effects of Pioglitazone in Combination with Metformin or a Sulfonylurea Compared to a Fixed-Dose Combination of Metformin and Glibenclamide in Patients with Type 2 Diabetes

Published in Diabetes Technology & Therapeutics • Aug 1, 2007

Authors:

Marco Comaschi

A Demicheli

Caterina Di Pietro

Abstract

BACKGROUND: This study was designed to compare the effectiveness of co-administration of pioglitazone with metformin or a sulfonylurea (SU), with a fixed-dose combination of metformin and glibenclamide on glycemic control and beta-cell function in patients with type 2 diabetes. METHODS: Patients (n ...

Subject

Metformin

Glibenclamide

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!